TSH Biopharm Corporation Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	559.66	464.54	588.34	576.59	488.9	381.89
Short-Term Investments	22.6	467.74	309.02	195.54	326.86	351.52
Cash & Short-Term Investments	582.27	932.28	897.36	772.12	815.77	733.41
Cash Growth	-34.90%	3.89%	16.22%	-5.35%	11.23%	1.07%
Accounts Receivable	209.06	312.34	211.68	208.33	202.55	99.07
Other Receivables	3.63	2.35	2.39	2.18	1.83	1.06
Receivables	212.69	314.69	214.07	210.51	204.38	100.13
Inventory	138.22	155.74	176.08	118.4	107.39	73.22
Prepaid Expenses	16.96	18.54	16.79	9.29	-	-
Other Current Assets	489.08	1.77	0.41	3.44	15.37	13.22
Total Current Assets	1,439	1,423	1,305	1,114	1,143	919.97
Property, Plant & Equipment	33.27	35.64	40.41	32.68	41.64	27.36
Long-Term Investments	181.08	183.84	192.63	188.89	179.08	212.06
Goodwill	-	247.9	247.9	-	-	-
Other Intangible Assets	292.66	41.58	39.75	53.64	64.07	3.63
Long-Term Deferred Tax Assets	2.67	2.67	4.01	1.51	1.8	2.01
Other Long-Term Assets	34.08	16.8	12.78	9.39	5.62	4.39
Total Assets	1,983	1,951	1,842	1,400	1,435	1,169
Accounts Payable	44.16	48.63	71.36	51.42	57.64	12.72
Accrued Expenses	-	67.87	56.69	35.21	37.4	44.77
Short-Term Debt	-	-	-	-	20	-
Current Portion of Long-Term Debt	-	-	-	-	18.85	-
Current Portion of Leases	11.07	11.95	10.1	7.4	7.32	4.57
Current Income Taxes Payable	39.8	26.68	32.23	2.97	8.02	7.1
Current Unearned Revenue	8.14	3.24	1.04	1.84	5.43	-
Other Current Liabilities	120.15	68.73	37.48	34.79	50.85	16.64
Total Current Liabilities	223.32	227.09	208.9	133.63	205.5	85.8
Long-Term Debt	-	-	-	-	9.6	-
Long-Term Leases	6.07	6.7	10.33	-	7.36	-
Total Liabilities	229.39	233.79	219.23	133.63	222.46	85.8
Common Stock	383.98	383.98	383.98	383.98	383.98	383.98
Additional Paid-In Capital	459.61	459.61	459.55	459.5	459.44	459.36
Retained Earnings	619.92	581.2	480.68	204.14	228.37	224.08
Comprehensive Income & Other	11.61	17.82	67.58	59.98	22.58	16.21
Total Common Equity	1,475	1,443	1,392	1,108	1,094	1,084
Minority Interest	278.45	275.06	231.18	158.63	118.31	-
Shareholders' Equity	1,754	1,718	1,623	1,266	1,213	1,084
Total Liabilities & Equity	1,983	1,951	1,842	1,400	1,435	1,169
Total Debt	17.14	18.64	20.43	7.4	63.13	4.57
Net Cash (Debt)	565.13	913.64	876.93	764.73	752.64	728.84
Net Cash Growth	-35.37%	4.19%	14.67%	1.60%	3.27%	1.67%
Net Cash Per Share	14.66	23.75	22.81	19.90	19.57	18.96
Filing Date Shares Outstanding	38.72	38.4	38.4	38.4	38.4	38.4
Total Common Shares Outstanding	38.72	38.4	38.4	38.4	38.4	38.4
Working Capital	1,216	1,196	1,096	980.13	937.41	834.17
Book Value Per Share	38.10	37.57	36.25	28.85	28.50	28.22
Tangible Book Value	1,182	1,153	1,104	1,054	1,030	1,080
Tangible Book Value Per Share	30.54	30.03	28.76	27.45	26.83	28.13
Land	-	5.85	5.85	5.85	5.85	5.85
Buildings	-	14.2	14.2	14.2	13.94	13.94
Machinery	-	48.21	47.68	33.13	31.41	22.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.